Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Detection Cartridges

By Drug Discovery Trends Editor | September 8, 2008

PARADIGM Detection Platform CartridgesBeckman Coulter offers four new cartridges for the PARADIGM Detection Platform, the company’s unique user-configurable and upgradeable multimode reader. The new cartridges increase the total number of interchangeable detection choices to 14, extending platform utility and return on investment for PARADIGM customers. The new options include two additional luminescence detection cartridges optimized for 96- and 384-well plate formats, a new detection cartridge for BRET2 (Bioluminescence Resonance Energy Transfer) live cell assays and a Rhodamine fluorescence cartridge for a selection of cyanine dyes.
The new Dual Luminescence Detection Cartridge is optimized for use with BRET2 live cell assays and includes predefined protocols and data analysis tools. This cartridge is ideal for the study of protein-protein interactions.

The new Fluorescence Intensity Detection Cartridge delivers speed and high sensitivity in applications using Cy3 and equivalent Rhodamine fluorescent labels. 

This new cartridge expands Beckman Coulter’s detection menu for FRET (Fluorescence Resonance Energy Transfer) assays by reading Cy3 paired with Cy5 or Cy5.5 dyes, which are commonly used in genomics and proteomics research.

www.beckmancoulter.com 

This article was published in Drug Discovery & Development magazine: Vol. 10, No. 9, September, 2008, pp. 8.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50